The price of Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) closed at $0.33 in the last session, down -5.20% from day before closing price of $0.35. In other words, the price has decreased by -$0.0180 from its previous closing price. On the day, 4115012 shares were traded.
Ratios:
We take a closer look at TNXP’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.02 and its Current Ratio is at 1.77. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On April 18, 2019, ROTH Capital Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $4.
ROTH Capital Upgraded its Neutral to Buy on August 18, 2017, while the target price for the stock was maintained at $6.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNXP now has a Market Capitalization of 19.43M and an Enterprise Value of 13.67M. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.64 while its Price-to-Book (P/B) ratio in mrq is 0.05. Its current Enterprise Value per Revenue stands at 3.43 whereas that against EBITDA is -0.11.
Stock Price History:
Over the past 52 weeks, TNXP has reached a high of $4.00, while it has fallen to a 52-week low of $0.26. The 50-Day Moving Average of the stock is 0.3368, while the 200-Day Moving Average is calculated to be 0.7521.
Shares Statistics:
According to the various share statistics, TNXP traded on average about 1.42M shares per day over the past 3-months and 1.58M shares per day over the past 10 days. A total of 80.82M shares are outstanding, with a floating share count of 80.81M. Insiders hold about 0.01% of the company’s shares, while institutions hold 20.77% stake in the company. Shares short for TNXP as of Feb 29, 2024 were 616.24k with a Short Ratio of 0.43, compared to 638.23k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.05% and a Short% of Float of 1.05%.
Earnings Estimates
The company has 3 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$1.64 for the current quarter, with a high estimate of -$1.46 and a low estimate of -$1.83, while EPS last year was -$3.5. The consensus estimate for the next quarter is -$1.35, with high estimates of -$1.35 and low estimates of -$1.35.
Analysts are recommending an EPS of between -$4.49 and -$8.8 for the fiscal current year, implying an average EPS of -$6.64. EPS for the following year is -$3.14, with 3 analysts recommending between -$0.91 and -$5.83.
